225
Views
2
CrossRef citations to date
0
Altmetric
Review

Endophthalmitis in HIV Infection

, MD, , MDORCID Icon, , MD, , MD & , MDORCID Icon
Pages 1060-1065 | Received 28 Sep 2019, Accepted 27 Nov 2019, Published online: 16 Jan 2020

References

  • Mamalis N. Endophthalmitis. J Cataract Refract Surg. 2002;28:729–730. doi:10.1016/s0886-3350(02)01350-0.
  • Durand ML. Endophthalmitis. Clin Microbiol Infect. 2013;19:227–234. doi:10.1111/1469-0691.12118.
  • Dave VP, Das T. Definition, signs, and symptoms of endophthalmitis. In: Das T, ed.. Endophthalmitis. A Guide to Diagnosis and Management. Singapore: Springer Nature Singapore Pte Ltd; 2018:3–4.
  • Jabbarvand M, Hashemian H, Khodaparast M, Jouhari M, Tabatabaei A, Rezaei S. Endophthalmitis occurring after cataract surgery: outcomes of more than 480,000 cataract surgeries, epidemiologic features, and risk factors. Ophthalmology. 2016;123:295–301. doi:10.1016/j.ophtha.2015.08.023.
  • Taban M, Behrens A, Newcomb RL. et al. Acute endophthalmitis following cataract surgery: a systematic review of the literature. Arch Ophthalmol. 2005;123:613–620. doi:10.1001/archopht.123.5.613.
  • Aaberg TM Jr, Flynn HW Jr, Schiffman J, Newton J. Nosocomial acute-onset postoperative endophthalmitis survey. A 10-year review of incidence and outcomes. Ophthalmology. 1998;105:1004–1010. doi:10.1016/S0161-6420(98)96000-6.
  • Rasmussen LD, Kessel L, Molander LD. et al. Risk of cataract surgery in HIV-infected individuals: a Danish nationwide population-based cohort study. Clin Infect Dis. 2001;53:1156–1163. doi:10.1093/cid/cir675.
  • Kempen JH, Sugar EA, Varma R. et al. Risk of cataract among subjects with acquired immune deficiency syndrome free of ocular opportunistic infections. Ophthalmology. 2014;121:2317–2324. doi:10.1016/j.ophtha.2014.06.014.
  • Jalali S. Post-cataract surgery endophthalmitis. In: Das T, ed.. Endophthalmitis. A Guide to Diagnosis and Management. Singapore: Springer Nature Singapore Pte Ltd; 2018:82.
  • Cao H, Zhang L, Li L, Lo S. Risk factors for acute endophthalmitis following cataract surgery: a systematic review and meta-analysis. PLoS One. 2013;8:e71731. doi:10.1371/journal.pone.0071731.
  • Chew GWM, Teoh SCB, Agrawal R. Analysis and outcomes of cataract surgery in patients with acquired immunodeficiency syndrome. Ocul Immunol Inflamm. 2017;25:535–539. doi:10.3109/09273948.2016.1158281.
  • Emparan C, Itruburu IM, Portugal V, Apecechea A, Bilbao JE, Mendez JJ. Infective complications after minor operations in patients infected with HIV: role of CD4 lymphocytes in prognosis. Eur J Surg. 1995;161:721–723.
  • Madiba TE, Muckart DJJ, Thomson SR. Human immunodeficiency disease: how should it affect surgical decision making? World J Surg. 2009;33:899–909. doi:10.1007/s00268-009-9969-6.
  • Senthil S, Garg P. Blebitis and bleb related endophthalmitis. In: Das T, ed. Endophthalmitis. A Guide to Diagnosis and Management. Singapore: Springer Nature Singapore Pte Ltd; 2018:93–100.
  • Centers for Disease Control and Prevention. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV. 2019. https://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf. Accessed September 18, 2019.
  • Fintak DR, Shah GK, Blinder KJ. et al. Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab. Retina. 2008;28:1395–1399. doi:10.1097/IAE.0b013e3181884fd2.
  • Baudouin C, Chassain C, Caujolle C, Gastaud P. Treatment of cytomegalovirus retinitis in AIDS patients using intravitreal injections of highly concentrated ganciclovir. Ophthalmologica. 1996;210:329–335. doi:10.1159/000310734.
  • Lim JI, Wolitz R, Dowlings AH, Bloom HR, Irvine AR, Schwartz DM. Visual and anatomic outcomes associated with posterior segment complications after ganciclovir implant procedures in patients with AIDS and cytomegalovirus retinitis. Am J Ophthalmol. 1999;127:288–293. doi:10.1016/s0002-9394(98)00443-7.
  • Martin DF, Dunn JP, Davis JL. et al. Use of the ganciclovir implant for the treatment of cytomegalovirus retinitis in the era of potent antiretroviral therapy: recommendations of the international AIDS society-USA panel. Am J Ophthalmol. 1999;127:329–339. doi:10.1016/s0002-9394(98)00441-3.
  • Shane TS, Martin DF. Endopthalmitis-gancioclovir implant study group. Endophthalmitis after ganciclovir implant in patients with AIDS and cytomegalovirus retinitis. Am J Ophthalmol. 2003;136:649–654. doi:10.1016/s0002-9394(03)00333-7.
  • Gokce G, Sobaci G, Ozgonul C. Post-traumatic endophthalmitis: a mini-review. Semin Ophthalmol. 2015;30:470–474. doi:10.3109/08820538.2013.877939.
  • Padhi TR. Traumatic Endophthalmitis. In: Das T, ed.. Endophthalmitis. A Guide to Diagnosis and Management. Singapore: Springer Nature Singapore Pte Ltd; 2018:105.
  • O’Neill EC, Yeoh J, Fabinyi DC. et al. Risk factors, microbial profiles and prognosis of microbial keratitis-associated endophthalmitis in high-risk eyes. Graefes Arch Clin Exp Ophthalmol. 2014;252:1457–1462. doi:10.1007/s00417-014-2732-1.
  • Faggian F, Azzini A, Lanzafame M. et al. Hyperacute unilateral gonococcal endophthalmitis in an HIV-infected man without genital infection. Eur J Ophthalmol. 2006;16:346–348. doi:10.1177/112067210601600226.
  • Henry CR, Flynn HW Jr., Miller D, Forster RK, Alfonso EC. Infectious keratitis progressing to endophthalmitis: a 15-year study of microbiology, associated factors, and clinical outcomes. Ophthalmology. 2012;119:2443–2449. doi:10.1016/j.ophtha.2012.06.030.
  • Malihi M, Li X, Patel S. et al. Infectious keratitis associated endophthalmitis: a 14-year study. Retina. 2017;37:662–666. doi:10.1097/IAE.0000000000001204.
  • Sadiq MA, Hassan M, Agarwal A. et al. Endogenous endophthalmitis: diagnosis, management and prognosis. J Ophthalmic Inflamm Infect. 2015;5:32. doi:10.1186/s12348-015-0063-y.
  • Read RW. Endophthalmitis. In: Yanoff M, Duker JS, eds. Ophthalmology. 2nd ed. St. Louis: Mosby; 2004:1153.
  • Wu ZH, Chan RP, Luk FO. et al. Review of clinical features, microbiological spectrum, and treatment outcomes of endogenous endophthalmitis over an 8-year period. J Ophthalmol. 2012;2012:265078. doi:10.1155/2012/265078.
  • Kresloff MS, Castellarin AA, Zarbin MA. Endophthalmitis. Surv Ophthalmol. 1998;43:193–224. doi:10.1016/s0039-6257(98)00036-8.
  • Connell PP, O’Neill EC, Fabinyi D. et al. Endogenous endophthalmitis: 10-year experience at a tertiary referral centre. Eye (Lond). 2011;25:66–72. doi:10.1038/eye.2010.145.
  • Zurlo JJ, Lane HC. Other bacterial infections. In: DeVita VT, Rosenberg SA, eds. AIDS: Etiology, Diagnosis, Treatment and Prevention. 4th ed. Philadelphia: Lippincott-Raven; 1997:259–265.
  • Taramasso L, Tatarelli P, Di Biagio A. Bloodstream infections in HIV-infected patients. Virulence. 2016;7:320–328. doi:10.1080/21505594.2016.1158359.
  • Mocroft A, Furrer HJ, Miro JM. et al. Opportunistic infections working group on behalf of the collaboration of observational HIV epidemiological research Europe (COHERE) study in EuroCOORD. The incidence of AIDS-defining illnesses at a current CD4 count 200 cells/mL in the post-combination antiretroviral therapy era. Clin Infect Dis. 2013;57:1038–1047. doi:10.1093/cid/cit423.
  • Vaziri K, Pershing S, Albini TA, Moshfeghi DM, Moshfeghi AA. Risk factors predictive of endogenous endophthalmitis among hospitalized patients with hematogenous infections in the United States. Am J Ophthalmol. 2015;159:498–504. doi:10.1016/j.ajo.2014.11.032.
  • Farber BP, Weinbaum DL, Dummer JS. Metastatic bacterial endophthalmitis. Arch Intern Med. 1985;145:62–64. doi:10.1001/archinte.1985.00360010082012.
  • Greenwald MJ, Wohl LG, Sell CH. Metastatic bacterial endophthalmitis: a contemporary reappraisal. Surv Ophthalmol. 1986;31:81–101. doi:10.1016/0039-6257(86)90076-7.
  • Okada AA, Johnson RP, Liles WC, D‘ Amico DJ, Baker AS. Endogenous bacterial endophthalmitis. Report of a ten-year retrospective study. Ophthalmology. 1994;101:832–838. doi:10.1016/S0161-6420(13)31255-X.
  • Binder MI, Chua J, Kaiser PK, Procop GW, Isada CM. Endogenous endophthalmitis: an 18-year review of culture-positive cases at a tertiary care center. Medicine (Baltimore). 2003;82:97–105. doi:10.1097/00005792-200303000-00004.
  • Maling S, King C, Davies N. A British ophthalmological surveillance unit study on metastatic endogenous endophthalmitis. Eye (Lond). 2018;32:743–748. doi:10.1038/eye.2017.284.
  • Nishida T, Ishida K, Niwa Y, et al. An eleven-year retrospective study of endogenous bacterial endophthalmitis. J Ophthalmol. 2015;261310. doi:10.1155/2015/261310.
  • Ness T, Pelz K, Hansen LL. Endogenous endophthalmitis: microorganisms, disposition and prognosis. Acta Ophthalmol Scand. 2007;85:852–856. doi:10.1111/j.1600-0420.2007.00982.x.
  • Ho V, Ho LY, Ranchod TM, Drenser KA, Williams GA, Garretson BR. Endogenous methicillin-resistant Staphylococcus aureus endophthalmitis. Retina. 2011;31:596–601. doi:10.1097/IAE.0b013e3181ecccf0.
  • Lee S, Um T, Joe SG, et al. Changes in the clinical features and prognostic factors of endogenous endophthalmitis: fifteen years of clinical experience in Korea. Retina. 2012;32:977–984. doi:10.1097/IAE.0b013e318228e312.
  • Schiedler V, Scott IU, Flynn HW, Davis JL, Benz MS, Miller D. Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes. Am J Ophthalmol. 2004;137:725–731. doi:10.1016/j.ajo.2003.11.013.
  • Freeman WR, Henderly DE, Lipson BK, Rao NA, Levine AM. Retinopathy before the diagnosis of AIDS. Ann Ophthalmol. 1989;21:468–474.
  • Tufail A, Weisz JM, Holland GN. Endogenous bacterial endophthalmitis as a complication of intravenous therapy for cytomegalovirus retinopathy. Arch Ophthalmol. 1996;114:879–880. doi:10.1001/archopht.1996.01100140093019.
  • Prajapati R, Newton P, Ahmad S, Kelly SP. Acute subretinal abscess in staphylococcus aureus septicaemia with endophthalmitis showcased by multimodal retinal imaging and with 2-year follow-up. BMJ Case Rep. 2018;11:e227288. doi:10.1136/bcr-2018-227288.
  • Rutar T, Chambers HF, Crawford JB. et al. Ophthalmic manifestations of infections caused by the USA300 clone of community-associated methicillin-resistant staphylococcus aureus. Ophthalmology. 2006;113:1455–1462. doi:10.1016/j.ophtha.2006.03.031.
  • Kashani AH, Eliott D. The emergence of Klebsiella pneumoniae endogenous endophthalmitis in the USA: basic and clinical advances. J Ophthalmic Inflamm Infect. 2013;3:28. doi:10.1186/1869-5760-3-28.
  • Shields RA, Smith SJ, Pan CK, Do DV. Endogenous Klebsiella pneumoniae endophthalmitis in Northern California. Retina. 2019;39:614–620. doi:10.1097/IAE.0000000000001994.
  • Li YH, Chen YH, Chen KJ. et al. Infectious Sources, prognostic factors, and visual outcomes of endogenous Klebsiella pneumoniae endophthalmitis. Ophthalmol Retina. 2018;2:771–778. doi:10.1016/j.oret.2017.11.013.
  • Yodprom R, Pathanapitoon K, Kunavisarut P, Ausayakhun S, Wattananikorn S, Rothova A. Endogenous endophthalmitis due to Salmonella choleraesuis in an HIV-positive patient. Ocul Immunol Inflamm. 2007;15:135–138. doi:10.1080/09273940701244228.
  • Jackson TL, Eykyn SJ, Graham EM, Stanford MR. Endogenous bacterial endophthalmitis: a 17 year prospective series and review of 267 reported cases. Surv Ophthalmol. 2003;48:403–423. doi:10.1016/s0039-6257(03)00054-7.
  • Wroblewski KJ, Hidayat AA, Neafie RC, Rao NA, Zapor M. Ocular tuberculosis: a clinicopathologic and molecular study. Ophthalmology. 2011;118:772–777. doi:10.1016/j.ophtha.2010.08.011.
  • Srichatrapimuk S, Wattanatranon D, Sungkanuparph S. Tuberculous panophthalmitis with lymphadenitis and central nervous system tuberculoma. Case Rep Infect Dis. 2016;2016:6785382. doi:10.1155/2016/6785382.
  • Babu RB, Sudharshan S, Kumarasamy N, Therese L, Biswas J. Ocular tuberculosis in acquired immunodeficiency syndrome. Am J Ophthalmol. 2006;142:413–418. doi:10.1016/j.ajo.2006.03.062.
  • Perlman DC, El-Helou P, Salomon N. Tuberculosis in patients with human immunodeficiency virus infection. Semin Respir Infect. 1999;14:344–352.
  • Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992;41:1–19.
  • Jackson TL, Paraskevopoulos T, Georgalas I. Systematic review of 342 cases of endogenous bacterial endophthalmitis. Surv Ophthalmol. 2014;59:627–635. doi:10.1016/j.survophthal.2014.06.002.
  • Sheu SJ, Kung YH, Wu TT, Chng FP, Horng YH. Risk factors for endogenous endophthalmitis secondary to klebsiella pneumoniae liver abscess: 20-year experience in Southern Taiwan. Retina. 2011;31:2026–2031. doi:10.1097/IAE.0b013e31820d3f9e.
  • Diamond RD. The growing problem of mycoses in patients infected with the human immunodeficiency virus. Rev Infect Dis. 1991;13:480–486. doi:10.1093/clinids/13.3.480.
  • Singh G, Wijesurendra CS, Green JT. Disseminated aspergillosis in the acquired immunodeficiency syndrome. Int J STD AIDS. 1994;5:63–66. doi:10.1177/095646249400500116.
  • Lingappan A, Wykoff CC, Albini TA. et al. Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes. Am J Ophthalmol. 2012;153:162–6.e1. doi:10.1016/j.ajo.2011.06.020.
  • Sridhar J, Flynn HW Jr, Kuriyan AE, Miller D, Albini T. Endogenous fungal endophthalmitis: risk factors, clinical features, and treatment outcomes in mold and yeast infections. J Ophthalmic Inflamm Infect. 2013;3:60. doi:10.1186/1869-5760-3-60.
  • Pelegrín L, Mesquida M, Adán A. et al. Candida dubliniensis endophthalmitis in a HIV-infected intravenous drug abuser. Mycoses. 2011;54:e856–8. doi:10.1111/j.1439-0507.2010.02000.x.
  • Miailhes P, Labetoulle M, Naas T. et al. Unusual etiology of visual loss in an HIV-infected patient due to endogenous endophthalmitis. Clin Microbiol Infect. 2001;7:641–645. doi:10.1046/j.1198-743x.2001.00276.x.
  • Jackson AP, Gamble JA, Yeomans T. et al. Comparative genomics of the fungal pathogens Candida dubliniensis and Candida albicans. Genome Res. 2009;19:2231–2244. doi:10.1101/gr.097501.109.
  • Klapholz A, Salomon N, Perlman DC, Talawera W. Aspergillosis in the acquired immunodeficiency syndrome. Chest. 1991;100:1614–1618. doi:10.1378/chest.100.6.1614.
  • Riddell IJ, McNeil SA, Johnson TM, Bradley SF, Kazanjian PH, Kauffman CA. Endogenous Aspergillus endophthalmitis: report of 3 cases and review of the literature. Medicine (Baltimore). 2002;81:311–320. doi:10.1097/00005792-200207000-00007.
  • Paula JS, Bryk A Jr, Lauretti Filho A, Romao E. Secondary glaucoma associated with bilateral Aspergillus niger endophthalmitis in an HIV-positive patient: case report. Arq Bras Oftalmol. 2006;69:395–397. doi:10.1590/s0004-27492006000300020.
  • Perri P, Campa C, Incorvaia C. et al. Endogenous Aspergillus versicolor endophthalmitis in an immuno-competent HIV-positive patient. Mycopathologia. 2005;160:259–261. doi:10.1007/s11046-005-6871-0.
  • Smith WM, Fahle G, Nussenblatt RB, Sen HN. A rare case of endogenous Aspergillus conicus endophthalmitis in an immunocompromised patient. J Ophthalmic Inflamm Infect. 2013;3:37. doi:10.1186/1869-5760-3-37.
  • Vrabec TR. Posterior segment manifestations of HIV/AIDS. Surv Ophthalmol. 2004;49:131–157. doi:10.1016/j.survophthal.2003.12.008.
  • Joseph J, Sharma S, Narayanan R. Endogenous cryptococcus neoformans endophthalmitis with subretinal abscess in a HIV-infected man. Indian J Ophthalmol. 2018;66:1015–1017. doi:10.4103/ijo.IJO_60_18.
  • Merkur AB, Hodge WG. Rhodotorula rubra endophthalmitis in an HIV positive patient. Br J Ophthalmol. 2002;86:1444–1445. doi:10.1136/bjo.86.12.1444.
  • Kurosawa A, Pollock SC, Collins MP, Kraff CR, Tso MO. Sporothrix schenckii endophthalmitis in a patient with human immunodeficiency virus infection. Arch Ophthalmol. 1988;106:376–380. doi:10.1001/archopht.1988.01060130402030.
  • Lipstein-Kresch E, Isenberg HD, Singer C, Cooke O, Greenwald RA. Disseminated sporothrix schenckii infection with arthritis in a patient with acquired immunodeficiency syndrome. J Rheumatol. 1985;12:805–808.
  • Silva-Vergara ML, de Camargo ZP, Silva PF. et al. Disseminated sporothrix brasiliensis infection with endocardial and ocular involvement in an HIV-infected patient. Am J Trop Med Hyg. 2012;86:477–480. doi:10.4269/ajtmh.2012.11-0441.
  • Kauffman CA. Sporotrichosis. Clin Infect Dis. 1999;29:231–236. doi:10.1086/520190.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.